219508-19-7 Usage
General Description
The chemical 3-Bromo-1H-indole-6-carboxylic acid, also known as 3-Bromoindole-6-carboxylic acid, is a derivative of indole with a carboxylic acid functional group attached to the sixth carbon atom and a bromine atom at the third position. It is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. This chemical has potential applications in the development of antineoplastic, antimicrobial, and antifungal agents. Its unique structure and functional groups make it a valuable building block for the creation of new compounds with diverse biological activities. Additionally, the presence of the bromine atom allows for further chemical modifications and diversification of its applications in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 219508-19-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,5,0 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 219508-19:
(8*2)+(7*1)+(6*9)+(5*5)+(4*0)+(3*8)+(2*1)+(1*9)=137
137 % 10 = 7
So 219508-19-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H6BrNO2/c10-7-4-11-8-3-5(9(12)13)1-2-6(7)8/h1-4,11H,(H,12,13)
219508-19-7Relevant articles and documents
SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF
-
Paragraph 0236; 0237, (2016/07/27)
Provided is a compound of formula (I)[Formula (I) should be inserted here], in which Ar1, R1, U, V, W, X, and p are as described herein. Also provided are methods of using a compound of formula (I), including a method of treating cancer, a method of treating a patient with cancer cells resistant to an anti-cancer agent, and a method of inhibiting lactate dehydrogenase A (LDHA) and/ or lactate dehydrogenase B (LDHB) activity in a cell.
Antithrombotic agents
-
, (2008/06/13)
This application relates to a compound of formula (I), a pharmaceutically acceptable salt of the compound, or a prodrug thereof, as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
